Cervical cancer screening device EVA VisualCheck AI

image recognition

MobileODT is creating a new paradigm in cervical screening, with EVA ,a digital mobile colposcope powered by Artificial Intelligence and telehealth capabilities . With over 300,000 women dying from cervical cancer each year, our ability to perform screening at scale , can play a pivotal role in supporting the World Health Organization strategic mission to eliminate cervical cancer by 2030. Over 180,000 cervical exams have been performed to date with the MobileODT EVA technology and our Artificial Intelligence application is used in a number of national screening projects, helping to diagnose hundreds of women with early stages of cervical cancer and potentially saving the lives of many of them. MobileODT's EVA System combines advanced imaging, data, and software applications enhancing patient access to quality care in more than 30 countries worldwide. The EVA System's smart mobile colposcope is used by clinicians for colposcopy, general gynecology, and Sexual Assault Forensics examination and documentation. The EVA SANE Visualization and Documentation technology are specifically designed to allow the sexual assault forensic nurses to focus on the patient, while easily capturing forensic findings. The company’s EVA VisualCheck AI technology offers an alternative screening modality to the current standard of care, with significantly improved accuracy and speed (giving results within 60 seconds). In addition, the MobileODT solution could be utilized by a broader range of healthcare specialists providing access to patients that otherwise would have not been screened